MeSH tree: C14.907.355.830.925
New research explores how hormonal contraceptive use may influence cardiovascular and thrombotic risk in women, including those with anxiety, depression or PTSD. Antonia Seligowski, Ph.D., of the Neurocardiac Effects of Stress ...
Feb 7, 2026
0
9
Patients with neuropathic bladder (NB), a condition in which nerve damage affects bladder function, have a significantly higher risk of joint infections, blood clots, and other adverse events after receiving total hip replacement ...
Jan 27, 2026
0
5
Retinal vein occlusion (RVO) is a severe disease that occurs when a vein in the light-sensitive layer at the back of the eye (i.e., the retina) becomes blocked, which results in a loss of vision. There are currently a few ...
Glossy social media ads promising "lunchtime fat removal" and "freckle-sized" scars draw thousands of patients to cosmetic surgery chains.
Jan 5, 2026
0
11
The Pooled Cohort Equations (PCE) cardiovascular risk score stratifies risk for multiple ocular diseases, according to a study published online in Ophthalmology.
Dec 31, 2025
0
61
At the University of Oulu in Finland, researchers are exploring new ways to utilize microwave technology in monitoring and assessing health conditions. The results of experiments conducted with realistic models are promising.
Nov 20, 2025
0
19
Retinal vein occlusion (RVO) is one of the leading causes of vision loss worldwide, often triggered by chronic diseases such as hypertension and diabetes. Similar to a blocked water pipe causing backflow and pressure buildup, ...
Oct 29, 2025
0
13
Pedestrian-motor vehicle accidents are a common cause of injury in both children and adults, accounting for one death every 64 minutes and injuring thousands every year. Two recent analyses reveal that while both adults and ...
Oct 3, 2025
0
18
In women with type 2 diabetes (T2D), use of hormone replacement therapy (HRT) skin patches is not associated with a higher risk of blood clots or stroke. However, an increased cardiovascular risk was found for oral HRT, according ...
Sep 14, 2025
0
24
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, according to late-breaking ...
Sep 1, 2025
0
21
